Clinical Trial Update: Pembrolizumab for Locally Advanced, Irresectable, Non-metastatic dMMR Colorectal Cancers [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pembrolizumab for locally advanced, unresectable, non-metastatic mismatch repair-deficient colorectal cancers is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Pembrolizumab (Keytruda) (pembrolizumab)

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Colorectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING